Diebold Nixdorf, Incorporated
NYSE:DBDSoftware - Application
+$1.71 today
- Market cap
- $1.77B
- Beta
- 1.13
- P/E (TTM)
- 26.9
- EPS (TTM)
- $3.07
Volume 0.27M
Average 0.43M
DBD Acquisitions (Net)
Cash paid for acquiring businesses, net of cash acquired.
Diebold Nixdorf, IncorporatedNYSE: DBD
Acquisitions (Net) · Q2 FY2026 · quarter ended Jun 2026
Acquisitions (net) outflow grows to $0
Q2 FY2026 acquisitions (net) was $0, compared with $0 a year earlier. Trailing-twelve-month acquisitions (net) was -$24.5M.
Context
- Acquisitions (net) amounted to 0.6% of revenue in FY2025, up 0.6 pp from a year earlier.
- Acquisitions (net) increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly acquisitions (net) holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$6.13M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Acquisitions (Net) history
USD · from the cash flow
- Latest · FY2025
- (24.5M) USD
- Year-over-year change
- —
| Period | Period end | Acquisitions (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (24.5M) | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 10.5M | -32.3% |
| FY2021 | 2021-12-31 | 15.5M | — |
Acquisitions (Net) vs competitors
How DBD compares with its peers on the latest reported figures
- DBD's LTM Jun 2026 acquisitions (net) of $24.5M is the 2nd largest of the 10 companies compared; the peer median is $0.
- Acquisitions (net) amounts to 0.6% of revenue for DBD, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $35.86M | -776.9% | — | 6.0% | |
| LTM Jun 2026 | $24.5M | — | — | 0.6% | |
| LTM Feb 2026 | $21.22M | -97.5% | — | 2.1% | |
| LTM Sep 2026 | $15.88M | +7153.0% | — | 0.9% | |
WBTNWEBTOON Entertainment Inc. Common stock | LTM Mar 2026 | $51K | +101.1% | -78.4% | 0.0% |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | +100.0% | +45.2% | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Apr 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | +100.0% | +41.7% | 0.0% | |
| Peer median (excluding DBD) | $0 | +100.0% | +41.7% | 0.0% | |
Competitors are the stored peer set for DBD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (78.8M) | (585.6M) | 1.38B | (14.5M) | 94.6M |
| Depreciation & Amortization | 149.1M | 126M | 136.3M | 132.3M | 127.5M |
| Deferred Income Tax | (12.6M) | 92.9M | 36.6M | (34.1M) | (48.1M) |
| Stock-Based Compensation | 0 | 13.4M | 0 | 9.7M | 0 |
| Change in Working Capital | 29.4M | (170M) | (182.5M) | 38.6M | 65.8M |
| Accounts Receivables | 16.4M | (49.4M) | (91.7M) | 99.6M | 25.9M |
| Inventory | (84.8M) | (74.5M) | 52.7M | 20.9M | 65.1M |
| Accounts Payables | 241.4M | (66.5M) | (65.4M) | (42.2M) | (68.3M) |
| Other Working Capital | (143.6M) | 20.4M | (78.1M) | (39.7M) | 43.1M |
| Other Non-Cash Items | 36.2M | 135.4M | (1.62B) | 17.2M | 60.9M |
| Operating Cash Flow | 123.3M | (387.9M) | (257M) | 149.2M | 300.7M |
| Capital Expenditures | (51.3M) | (53.1M) | (24.9M) | (17.4M) | (37.4M) |
| Acquisitions (Net) | 15.5M | 10.5M | 0 | 0 | (24.5M) |
| Purchases of Investments | (288.4M) | (401.3M) | (270.5M) | (295.2M) | (318.4M) |
| Sales of Investments | 287.7M | 414.1M | 282.2M | 288.8M | 306M |
| Other Investing Activities | 0 | 6M | 0 | (21.7M) | 1M |
| Investing Cash Flow | (36.5M) | (23.8M) | (36.1M) | (45.5M) | (97.6M) |
| Debt Repayment | (7.3M) | 376.1M | 565.2M | (300.1M) | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (130.7M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (9M) | (26.3M) | (5.7M) | (66.4M) | (13.2M) |
| Financing Cash Flow | (16.3M) | 349.8M | 559.5M | (366.5M) | (143.9M) |
| Effect of Forex Changes | (6.1M) | (8.2M) | 6.8M | (18.2M) | 16.8M |
| Net Change in Cash | 64.4M | (69.8M) | 273.2M | (281M) | 76M |
| Free Cash Flow | 72M | (441M) | (281.9M) | 131.8M | 263.3M |
Diebold Nixdorf, Incorporated
NYSE:DBD
Intrinsic Alpha fair value
Locked
Current Price
$52.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.